|
NEW JERSEY ALLIANCE FOR
CLINICAL AND TRANSLATIONAL SCIENCE
NEWS, EVENTS, and DEADLINES
June 27, 2022
| |
Upcoming NJ ACTS and Rutgers Events | |
|
NJ ACTS Workforce Core
Python Advanced Training
| |
Join New Jersey Institute of Technology Associate Professor of Business Data Science, MT School of Management
Dantong Yu, PhD
For live training sessions where you will gain hands-on experience while practicing with real-life Machine Learning examples
ADVANCED TRAINING
- Support Vector Machine In-Depth
- Prediction via Evidence Combination
- Representing and Mining Text: Text and Sentiment Analysis
- Unsupervised Learning Algorithms
- Deep Learning
June 28, 2022
10 am - 2 pm
Register Here
View Flyer
Read More about Workforce Core
| |
|
Rutgers Institute for Translational Medicine and Science
A Translational Approach to
Investigating Lung Regenerative and Fibrotic Responses
| |
|
Vibha Lama, MD, MS
Professor and Vice Chair, Basic and Translational Research, Department of Medicine
Henry Sewall Research Professor of Pulmonary/Critical Care Medicine
Associate Chief, Division of Pulmonary/Critical Care Medicine
University of Michigan
June 28, 2022
12 pm - 1 pm
Join via Zoom
View Flyer
| |
NJ ACTS Congratulates Ryan Dikdan
Ryan Dikdan, a doctoral MD, PhD student at Rutgers New Jersey Medical School and current NJ ACTS TL1 Fellow, is part of the team that created a test that easily detects which variant of the virus causing COVID-19 has infected a person.
This advance is expected to greatly assist health officials tracking the disease and physicians treating infected patients.
Details of the PCR (polymerase chain reaction) test have been published in their article Multiplex PCR Assays for Identifying all Major Severe Acute Respiratory Syndrome Coronavirus 2 Variants in The Journal of Molecular Diagnostics.
Read more about the TL1 Fellows Program.
| |
|
NJ ACTS Stakeholder Satisfaction Survey | |
|
Please participate in the Rutgers Institute for Translational Medicine and Science (RITMS) Stakeholder Satisfaction Survey. This survey specifically focuses on RITMS’ Service-Driven, Translational Science Programs, including NJ ACTS. You can access the on-line survey at: https://redcap.rwjms.rutgers.edu/surveys/?s=JYJN3RYPT9.
Your participation in the survey helps us improve the services offered and directly affects the allocation of financial resources to services that will meet your future needs. In addition to improving our services, your feedback will be discussed at the RITMS Review Committee meetings and included in the RITMS External Review Report. Our responsiveness to your comments is evaluated by the RITMS External Advisory Board every five years during our designation.
While you can participate anonymously, we ask that you complete your personal information so that we can address your specific comments. The information you submit will be anonymized before communicating your responses to each question. After entering your information, please select the survey question you want to address and fill in as applicable.
Please share this survey with your any of your peers who have used any RITMS/NJ ACTS service. For any questions, please reach out to Dr. Karen D’Alonzo, Associate Professor, School of Nursing at kdalonzo@sn.rutgers.edu.
Thank you.
The RITMS/NJ ACTS Internal Review Committee
| |
NJ ACTS Services: Scientific Review Board | |
NJ ACTS Regulatory Knowledge and Support Core
Scientific Review Board (SRB) Services
The NJACTS Scientific Review Board supports investigator-initiated studies by reviewing non-oncology protocols to assess proper statistical design, enrollment goals, feasibility (including adequate research staffing, competing trials, funding, resources, and departmental support) to help accelerate IRB approval and to help ensure study success.
Read more about SRB Services
Questions? Contact the SRB
| |
|
2022 In-Person CTSA Program Annual Meeting
Meeting Theme:
Achieving Health Equity through the Science of Translation
Venue:
Omni Shoreham Hotel
Washington DC
November 1-2, 2022
Check out the meeting event page and watch for details to come!
| |
National Institutes of Health (NIH) Data | |
|
All of Us Research Program
Data Expansion Bolsters Trove of COVID-19 Information
Researcher Workbench expands participant data to drive unique insights
Health data from nearly 20,000 people who have had SARS-CoV-2 is now available to researchers across the U.S., opening new opportunities to study COVID-19 disease prevention, progression, and recovery. These records, encompassing clinical, genomic, and participant-reported information, are part of the National Institutes of Health's All of Us Research Program's latest data expansion.
In addition to the COVID-19 data, the program has added more than 57,000 initial responses from its new social determinants of health (SDOH) survey to drive novel insights into how lived experiences affect health. In total, the Researcher Workbench now includes data from more than 372,000 participants, nearly 80% of whom identify with groups historically underrepresented in medical research.
This latest data refresh represents the second update to the Researcher Workbench this year, following the release of nearly 100,000 whole genome sequences and more than 165,000 genotyping arrays in March 2022. The next data release is planned for this winter, to include another large infusion of genomic data and more.
| |
|
Oncostatin M expression in induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma. Headland SE, Dengler HS, Xu D, Teng G, Everett C, Ratsimandresy RA, Yan D, Kang J, Ganeshan K, Nazarova EV, Gierke S, Wedeles CJ, Guidi R, DePianto DJ, Morshead KB, Huynh A, Mills J, Flanagan S, Hambro S, Nunez V, Klementowicz JE, Shi Y, Wang J, Bevers J 3rd, Ramirez-Carrozzi V, Pappu R, Abbas A, Vander Heiden J, Choy DF, Yadav R, Modrusan Z, Panettieri RA Jr, Koziol-White C, Jester WF Jr, Jenkins BJ, Cao Y, Clarke C, Austin C, Lafkas D, Xu M, Wolters PJ, Arron JR, West NR, Wilson MS. Sci Transl Med. 2022 Jan 12;14(627):eabf8188. PMID: 35020406 DOI: 10.1126/scitranslmed.abf8188 Epub 2022 Jan 12.
Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. Martin B, DeWitt PE, Russell S, Anand A, Bradwell KR, Bremer C, Gabriel D, Girvin AT, Hajagos JG, McMurry JA, Neumann AJ, Pfaff ER, Walden A, Wooldridge JT, Yoo YJ, Saltz J, Gersing KR, Chute CG, Haendel MA, Moffitt R, Bennett TD. JAMA Netw Open. 2022 Feb 1;5(2):e2143151. DOI: 10.1001/jamanetworkopen.2021.43151. PMID: 35133437. PMCID: PMC8826712.
| |
MS in Clinical Research Management - Rutgers School of Health Professions is inviting all students interested in learning more about how to conduct clinical research at an Academic Medical Center. Now accepting applications for Fall 2022! This 16-month program is designed for students with no clinical research or pharmaceutical experience interested in functioning as a “study coordinator”. TO APPLY, CLICK HERE. To read more View Flyer. | |
|
On the Pandemic Podcast - The Impact of Race on Health with host Mary Marchetta O'Dowd, MPH, Executive Director, Health Systems and Population Health Integration, Rutgers Biomedical and Health Sciences and guest Denise V. Rodgers, MD, FAAFP, Vice Chancellor of Interprofessional Programs, Rutgers Biomedical and Health Sciences
Listen on : APPLE, SPOTIFY, GOOGLE, ANCHOR, RADIO PUBLIC
| |
Build a Successful Collaboration with NJ ACTS Team Science - The Team Science Core offers general and project-specific consultations on building and maintaining successful research teams and collaborations. To set up a consultation, please fill out the intake form. Read more about the Team Science Core.
| |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health. | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
| | | | | |
